ICND2020: International Conference on Nanomedicine and Drug Delivery Systems (Nano Delivery-2020), is a CPD accredited international conference with the theme "Nanomedicine and Drug Delivery Systems (DDSs): Recent developments and future prospects" which will be held during April 15-17, 2020 in Tokyo, Japan is now an established event, attracting global participant’s intent on sharing, exchanging and exploring new avenues of Nanomedicine and Drug Delivery and related research and latest developments.

Dr. Hiroshi Maeda, Director, BioDynamics Research Foundation, Japan. The Most cited influential scientist in Chemistry and Pharmacology by Thomson Reuters, Creator of the world first polymeric-conjugate drug, SMANCS with H-index of 120, will be our Honorable guest and the Poster judge (Best Poster Award = USD 299).

For more PS: https://frontiersmeetings.com/conferences/nanomedicine/ 

This three-day international event will have 40+ plenary speakers and more than 10 Keynote Speakers including academicians and industry veterans. It’s a forum to explore problems popped up during real-time to the researches and come up with all sorts of awareness and solution-oriented discussions in the Pharmaceutical field.

Who should attend:

Nano Science and Nano Technology Researchers

Nano Science and Nano Technology Associations and Societies

Drug Delivery researchers

Pharmaceutical Researchers

Professors, Associate Professors, Asst. Professors, Scientists

Graduates and Post Graduates

Directors, Presidents, CEO's of Organizations/Companies

Noble laureates in Health Care and Medicine

Medical Devices and Pharmaceuticals companies

Tool and Materials companies

Sessions:

Advanced Nanomedicine

Design of Nanodrugs

Personalized Nanomedicine

Recent Nanomaterials for drug delivery

Emerging technologies on Nanomedicine and Nanotechnology

Synthesis of Nanoparticles for Drug Delivery

Nanomedicine in Theranostics

Drug Delivery Research

Novel Drug Delivery Systems

Smart Drug Delivery Technology

Graphene Medicine

Tissue Engineering and Regenerative Medicine

Nanopharmaceuticals

Biopharmaceutics and Biologic Drugs

Nano Toxicology

Major challenges in Nano Pharmaceutical Industry and Market

Regulatory Aspects Towards Approval of Nanomedicine